V011-2562 Screening compound: ethyl 2-(5-methyl-7-{4-[2-(pyridin-4-yl)ethyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)acetate

V011-2562 Screening compound: ethyl 2-(5-methyl-7-{4-[2-(pyridin-4-yl)ethyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)acetate
V011-2562 Screening compound: ethyl 2-(5-methyl-7-{4-[2-(pyridin-4-yl)ethyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)acetate alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-2562
ethyl 2-(5-methyl-7-{4-[2-(pyridin-4-yl)ethyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)acetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-2562

Molecular Formula

C21H27N7O2 (C21 H27 N7 O2)

Compound Name

ethyl 2-(5-methyl-7-{4-[2-(pyridin-4-yl)ethyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)acetate

IUPAC name

ethyl 2-(5-methyl-7-{4-[2-(pyridin-4-yl)ethyl]piperazin-1-yl}-[124]triazolo[15-a]pyrimidin-6-yl)acetate

SMILES

CCOC(Cc(c(C)nc1ncnn11)c1N1CCN(CCc2ccncc2)CC1)=O

InChI

InChI=1S/C21H27N7O2/c1-3-30-19(29)14-18-16(2)25-21-23-15-24-28(21)20(18)27-12-10-26(11-13-27)9-6-17-4-7-22-8-5-17/h4-5,7-8,15H,3,6,9-14H2,1-2H3

InChI Key

AHBPVGMHRGCGBM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19959726

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

409.49

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.269

Distribution Coefficient, logD

0.622

Water Solubility, LogSw

-1.40

Polar Surface Area

67.681

Acid Dissociation Constant (pKa)

12.53

Base Dissociation Constant (pKb)

7.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.60

V011-2562 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Integrin Receptors Targeted library (1715 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V011-2562 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-2562?
Check Price and Availability of V011-2562, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-2562 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-2562
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-2562
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-2562 available by request